Breast Cancer Lymphedema
Conditions
Interventions
This research is a single-blind randomized clinical trial, in which participants will be randomly allocated to receive the intervention intended for their group, which will evaluate the effects of res
E01.370.600.425
Sponsors
Universidade Federal de Santa Maria
Universidade Federal de Santa Maria
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Women over 18 years old; who were diagnosed with breast cancer; underwent surgery with axillary dissection; upper limb lymphedema
Exclusion criteria
Exclusion criteria: Mastectomy with bilateral dissection; metastases diagnosed and described in the medical record; angina, diagnosed heart or kidney pathology; previous dysfunction of circulatory or musculoskeletal upper limbs; patients without cognitive conditions to understand the proposed exercises; pregnant women; diagnosed with rheumatological, autoimmune pathologies; with skin lesions that make lymphatic drainage and functional compressive bandaging unfeasible
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that there will be a reduction in lymphedema volume after 6 weeks, verified by the volumetry calculated by the Truncated Cone Formula, based on a reduction of at least 10% in pre- and post-intervention measurements | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that there is an improvement in the functionality of the upper limb, verified by the DASH questionnaire, from a reduction of at least 10 points after the 6-week protocol | — |
Countries
Brazil
Contacts
Public ContactHedioneia Pivetta
Universidade Federal de Santa Maria
Outcome results
None listed